Last reviewed · How we verify
BCX4430
At a glance
| Generic name | BCX4430 |
|---|---|
| Sponsor | BioCryst Pharmaceuticals |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BCX4430 CI brief — competitive landscape report
- BCX4430 updates RSS · CI watch RSS
- BioCryst Pharmaceuticals portfolio CI